SCOPUS 정보 검색 플랫폼

Volumn 72, Issue 3, 1998, Pages 2335-2340

A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine

(5) Smith, Robert A a,b Remington, Kathryn M a,e Preston, Bradley D b Schinazi, Raymond F c North, Thomas W a,d

a UNIVERSITY OF MONTANA (United States)

b UNIVERSITY OF UTAH SCHOOL OF MEDICINE (United States)

c EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

d UNIVERSITY OF CALIFORNIA (United States)

e BAYER CORPORATION (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG RESISTANCE; FELINE IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0031911770 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/jvi.72.3.2335-2340.1998 Document Type: Article

Times cited : (23)

References (62)

1
- 0025049031
- Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus
- Ackley, C. D., J. K. Yamamoto, N. Levy, N. C. Pedersen, and M. D. Cooper. 1990. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:5652-5655.
- (1990) J. Virol. , vol.64 , pp. 5652-5655
- Ackley, C.D.¹ Yamamoto, J.K.² Levy, N.³ Pedersen, N.C.⁴ Cooper, M.D.⁵

2
- 0029912274
- Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription
- Arts, E. J., and M. A. Wainberg. 1996. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 40:527-540.
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 527-540
- Arts, E.J.¹ Wainberg, M.A.²

3
- 0029757751
- Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme
- Back, N. K. T., M. Nijhuis, W. Keulen, C. A. B. Boucher, B. B. O. Essink, A. B. P. van Kuilenburg, A. H. van Gennip, and B. Berkhout. 1996. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:4040-4049.
- (1996) EMBO J. , vol.15 , pp. 4040-4049
- Back, N.K.T.¹ Nijhuis, M.² Keulen, W.³ Boucher, C.A.B.⁴ Essink, B.B.O.⁵ Van Kuilenburg, A.B.P.⁶ Van Gennip, A.H.⁷ Berkhout, B.⁸

4
- 0026029861
- Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: Comparison of short-term and long-term infections
- Barlough, J. E., C. D. Ackley, J. W. George, N. Levy, R. Acevedo, P. F. Moore, B. A. Rideout, M. D. Cooper, and N. C. Pedersen. 1991. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquired Immune Defic. Syndr. 4:219-227.
- (1991) J. Acquired Immune Defic. Syndr. , vol.4 , pp. 219-227
- Barlough, J.E.¹ Ackley, C.D.² George, J.W.³ Levy, N.⁴ Acevedo, R.⁵ Moore, P.F.⁶ Rideout, B.A.⁷ Cooper, M.D.⁸ Pedersen, N.C.⁹

5
- 0026534342
- Synthesis of enantiomerically pure (2′R,5′S)-(-)-1-[2-(hydroxymethyl)-oxathiolan-5-yl] cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV)
- Beach, J. W., L. S. Jeong, A. J. Alves, D. Pohl, H. O. Kim, C.-N. Chang, S.-L. Doong, R. F. Schinazi, Y.-C. Cheng, and C. K. Chu. 1992. Synthesis of enantiomerically pure (2′R,5′S)-(-)-1-[2-(hydroxymethyl)-oxathiolan-5-yl] cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 57:2217-2219.
- (1992) J. Org. Chem. , vol.57 , pp. 2217-2219
- Beach, J.W.¹ Jeong, L.S.² Alves, A.J.³ Pohl, D.⁴ Kim, H.O.⁵ Chang, C.-N.⁶ Doong, S.-L.⁷ Schinazi, R.F.⁸ Cheng, Y.-C.⁹ Chu, C.K.¹⁰

6
- 0027373308
- High-level resistance to (-) enantiomeric 2′-deoxy-3′-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase
- Boucher, C. A. B., N. Cammack, P. Schipper, R. Schuurman, P. Rouse, M. A. Wainberg, and J. M. Cameron. 1993. High-level resistance to (-) enantiomeric 2′-deoxy-3′-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 37:2231-2234.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 2231-2234
- Boucher, C.A.B.¹ Cammack, N.² Schipper, P.³ Schuurman, R.⁴ Rouse, P.⁵ Wainberg, M.A.⁶ Cameron, J.M.⁷

7
- 12044254762
- In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of oxathiolanyl and dioxythiolanyl nucleoside analogs
- Choi, C. K., J. W. Beach, L. J. Wilson, S. Yeola, D. C. Liotta, and R. F. Schinazi. 1991. In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of oxathiolanyl and dioxythiolanyl nucleoside analogs. J. Am. Chem. Soc. 113:9337-9379.
- (1991) J. Am. Chem. Soc. , vol.113 , pp. 9337-9379
- Choi, C.K.¹ Beach, J.W.² Wilson, L.J.³ Yeola, S.⁴ Liotta, D.C.⁵ Schinazi, R.F.⁶

8
- 0028943992
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
- Condra, J. H., W. A. Schieif, O. M. Blahy, L. J. Gabryelski, D. J. Graham, J. C. Quintero, A. Rhodes, H. L. Robbins, E. Roth, M. Shivaprakash, D. Titus, T. Yang, H. Teppler, K. E. Squires, P. J. Deutsch, and E. A. Emini. 1995. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (London) 374:569-571.
- (1995) Nature (London) , vol.374 , pp. 569-571
- Condra, J.H.¹ Schieif, W.A.² Blahy, O.M.³ Gabryelski, L.J.⁴ Graham, D.J.⁵ Quintero, J.C.⁶ Rhodes, A.⁷ Robbins, H.L.⁸ Roth, E.⁹ Shivaprakash, M.¹⁰ Titus, D.¹¹ Yang, T.¹² Teppler, H.¹³ Squires, K.E.¹⁴ Deutsch, P.J.¹⁵ Emini, E.A.¹⁶

9
- 0026806042
- Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2′-deoxyadenosine-5′-triphosphate
- Cronn, R. C., K. M. Remington, B. D. Preston, and T. W. North. 1992. Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2′-deoxyadenosine-5′-triphosphate. Biochem. Pharmacol. 44:1375-1381.
- (1992) Biochem. Pharmacol. , vol.44 , pp. 1375-1381
- Cronn, R.C.¹ Remington, K.M.² Preston, B.D.³ North, T.W.⁴

10
- 0028937012
- Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy
- D'Aquila, R. T., V. A. Johnson, S. L. Welles, A. J. Japour, D. R. Kuritzkes, V. DeGruttola, P. S. Reichelderfer, R. W. Coombs, C. S. Crumpacker, J. O. Kahn, and D. D. Richman. 1995. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. Ann. Intern. Med. 122:401-408.
- (1995) Ann. Intern. Med. , vol.122 , pp. 401-408
- D'Aquila, R.T.¹ Johnson, V.A.² Welles, S.L.³ Japour, A.J.⁴ Kuritzkes, D.R.⁵ Degruttola, V.⁶ Reichelderfer, P.S.⁷ Coombs, R.W.⁸ Crumpacker, C.S.⁹ Kahn, J.O.¹⁰ Richman, D.D.¹¹

11
- 0027964486
- Development of clinical disease in cats experimentally infected with feline immunodeficiency virus
- English, R. V., P. Nelson, C. M. Johnson, M. Nasisse, W. A. Tompkins, and M. B. Tompkins. 1994. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170:543-552.
- (1994) J. Infect. Dis. , vol.170 , pp. 543-552
- English, R.V.¹ Nelson, P.² Johnson, C.M.³ Nasisse, M.⁴ Tompkins, W.A.⁵ Tompkins, M.B.⁶

12
- 0026529145
- Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine
- Fitzgibbon, J. E., R. M. Howell, C. A. Haberzettl, S. J. Sperber, D. J. Gocke, and D. T. Dubin. 1992. Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 36:153-157.
- (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 153-157
- Fitzgibbon, J.E.¹ Howell, R.M.² Haberzettl, C.A.³ Sperber, S.J.⁴ Gocke, D.J.⁵ Dubin, D.T.⁶

13
- 0027506940
- Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine
- Gao, Q., Z. Gu, J. Hiscott, G. Dionne, and M. A. Wainberg. 1993. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37:130-133.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 130-133
- Gao, Q.¹ Gu, Z.² Hiscott, J.³ Dionne, G.⁴ Wainberg, M.A.⁵

14
- 0027155374
- The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine
- Gao, Q., Z. Gu, M. A. Parniak, I. Cameron, N. Cammack, C. Boucher, and M. A. Wainberg. 1993. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37:1390-1392.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 1390-1392
- Gao, Q.¹ Gu, Z.² Parniak, M.A.³ Cameron, I.⁴ Cammack, N.⁵ Boucher, C.⁶ Wainberg, M.A.⁷

15
- 0026542755
- In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine
- Gao, Q., Z. Gu, M. A. Parniak, X. Li, and M. A. Wainberg. 1992. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine. J. Virol. 66:12-19.
- (1992) J. Virol. , vol.66 , pp. 12-19
- Gao, Q.¹ Gu, Z.² Parniak, M.A.³ Li, X.⁴ Wainberg, M.A.⁵

16
- 0028209173
- Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2′,3′-dideoxyinosine alone and in combination with 3′-azido-3′-deoxythymidine
- Gobert, J. M., K. M. Remington, Y.-Q. Zhu, and T. W. North. 1994. Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2′,3′-dideoxyinosine alone and in combination with 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 38:861-864.
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 861-864
- Gobert, J.M.¹ Remington, K.M.² Zhu, Y.-Q.³ North, T.W.⁴

17
- 0028057581
- Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine
- Gu, Z., Q. Gao, H. Fang, H. Salomon, M. A. Parniak, E. Goldberg, J. Cameron, and M. A. Wainberg. 1994. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 38:275-281.
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 275-281
- Gu, Z.¹ Gao, Q.² Fang, H.³ Salomon, H.⁴ Parniak, M.A.⁵ Goldberg, E.⁶ Cameron, J.⁷ Wainberg, M.A.⁸

18
- 0026483089
- Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2′,3′-dideoxy-5-fluoro-3′-thiacytidine [(-(-FTC] and related compounds
- Hoong, L. K., L. E. Strange, D. C. Liotta, G. W. Koszalka, C. L. Burns, and R. F. Schinazi. 1992. Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2′,3′-dideoxy-5-fluoro-3′-thiacytidine [(-(-FTC] and related compounds. J. Org. Chem. 57:5563-5585.
- (1992) J. Org. Chem. , vol.57 , pp. 5563-5585
- Hoong, L.K.¹ Strange, L.E.² Liotta, D.C.³ Koszalka, G.W.⁴ Burns, C.L.⁵ Schinazi, R.F.⁶

19
- 0030048748
- Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral chemotherapy
- Iversen, A. K. N., R. W. Shafer, K. Wehrly, M. A. Winters, J. I. Mullins, B. Chesebro, and T. C. Merigan. 1996. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral chemotherapy. J. Virol. 70:1086-1090.
- (1996) J. Virol. , vol.70 , pp. 1086-1090
- Iversen, A.K.N.¹ Shafer, R.W.² Wehrly, K.³ Winters, M.A.⁴ Mullins, J.I.⁵ Chesebro, B.⁶ Merigan, T.C.⁷

20
- 0027318776
- Crystal structure of human immunodeficiency virus reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA
- Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, A. Hizi, S. H. Hughes, and E. Arnold. 1993. Crystal structure of human immunodeficiency virus reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 6320-6324
- Jacobo-Molina, A.¹ Ding, J.² Nanni, R.G.³ Clark Jr., A.D.⁴ Lu, X.⁵ Tantillo, C.⁶ Williams, R.L.⁷ Kamer, G.⁸ Ferris, A.L.⁹ Clark, P.¹⁰ Hizi, A.¹¹ Hughes, S.H.¹² Arnold, E.¹³

21
- 0028843163
- Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959
- Jacobsen, H., K. Yasargil, D. L. Winslow, J. C. Craig, A. Krohn, I. B. Duncan, and J. Mous. 1995. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology 206:527-534.
- (1995) Virology , vol.206 , pp. 527-534
- Jacobsen, H.¹ Yasargil, K.² Winslow, D.L.³ Craig, J.C.⁴ Krohn, A.⁵ Duncan, I.B.⁶ Mous, J.⁷

22
- 0028286025
- Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease
- Kaplan, A. H., S. F. Michael, R. S. Wehbie, M. F. Knigge, D. A. Paul, L. Event, D. J. Kempf, D. W. Norbeck, J. W. Erickson, and R. Swanstrom. 1994. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc. Natl. Acad. Sci. USA 91:5597-5601.
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 5597-5601
- Kaplan, A.H.¹ Michael, S.F.² Wehbie, R.S.³ Knigge, M.F.⁴ Paul, D.A.⁵ Event, L.⁶ Kempf, D.J.⁷ Norbeck, D.W.⁸ Erickson, J.W.⁹ Swanstrom, R.¹⁰

23
- 0030896362
- Initial appearance of 184Ile variant in lamivudine-treated patients can be explained by the mutational bias of human immunodeficiency virus reverse transcriptase
- Keulen, W., N. K. T. Back, A. van Wijk, C. Boucher, and B. Berkhout. 1997. Initial appearance of 184Ile variant in lamivudine-treated patients can be explained by the mutational bias of human immunodeficiency virus reverse transcriptase. J. Virol. 71:3346-3350.
- (1997) J. Virol. , vol.71 , pp. 3346-3350
- Keulen, W.¹ Back, N.K.T.² Van Wijk, A.³ Boucher, C.⁴ Berkhout, B.⁵

24
- 0026693137
- Crystal structure at 3.5 Å of HIV-1 reverse transcriptase complexed with an inhibitor
- Kohlstaedt, L. A., J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1992. Crystal structure at 3.5 Å of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
- (1992) Science , vol.256 , pp. 1783-1790
- Kohlstaedt, L.A.¹ Wang, J.² Friedman, J.M.³ Rice, P.A.⁴ Steitz, T.A.⁵

25
- 0026042638
- Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture
- Larder, B. A., K. E. Coates, and S. D. Kemp. 1991. Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J. Virol. 65:5232-5236.
- (1991) J. Virol. , vol.65 , pp. 5232-5236
- Larder, B.A.¹ Coates, K.E.² Kemp, S.D.³

26
- 0024508058
- HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
- Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
- (1989) Science , vol.243 , pp. 1731-1734
- Larder, B.A.¹ Darby, G.² Richman, D.D.³

27
- 0024310253
- Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
- Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246: 1155-1158.
- (1989) Science , vol.246 , pp. 1155-1158
- Larder, B.A.¹ Kemp, S.D.²

28
- 0029028067
- Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
- Larder, B. A., S. D. Kemp, and P. R. Harington. 1995. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269:696-699.
- (1995) Science , vol.269 , pp. 696-699
- Larder, B.A.¹ Kemp, S.D.² Harington, P.R.³

29
- 0029815110
- Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
- Ling, R., D. Mortimer, M. Ahmed, E. H. Boxall, E. Elias, G. M. Dusheiko, and T. J. Harrison. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
- (1996) Hepatology , vol.24 , pp. 711-713
- Ling, R.¹ Mortimer, D.² Ahmed, M.³ Boxall, E.H.⁴ Elias, E.⁵ Dusheiko, G.M.⁶ Harrison, T.J.⁷

30
- 0027379732
- Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro
- Mathez, D., R. F. Schinazi, D. Liotta, and J. Leibowitch. 1993. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro. Antimicrob. Agents Chemother. 37:875-881.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 875-881
- Mathez, D.¹ Schinazi, R.F.² Liotta, D.³ Leibowitch, J.⁴

31
- 0029865203
- Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2′,3′-dideoxycytidine
- Medlin, H. K., Y.-Q. Zhu, K. M. Remington, T. R. Phillips, and T. W. North. 1996. Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 40: 953-957.
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 953-957
- Medlin, H.K.¹ Zhu, Y.-Q.² Remington, K.M.³ Phillips, T.R.⁴ North, T.W.⁵

32
- 0029968740
- Closing in on human immunodeficiency virus-1
- Mellors, J. W. 1996. Closing in on human immunodeficiency virus-1. Nat. Med. 2:274-275.
- (1996) Nat. Med. , vol.2 , pp. 274-275
- Mellors, J.W.¹

33
- 0024998733
- Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses
- North, T. W., R. C. Cronn, K. M. Remington, and R. T. Tandberg. 1990. Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses. Antimicrob. Agents Chemother. 34:1505-1507.
- (1990) Antimicrob. Agents Chemother. , vol.34 , pp. 1505-1507
- North, T.W.¹ Cronn, R.C.² Remington, K.M.³ Tandberg, R.T.⁴

34
- 0025248568
- Characterization of reverse transcriptase from feline immunodeficiency virus
- North, T. W., R. C. Cronn, K. M. Remington, R. T. Tandberg, and R. C. Judd. 1990. Characterization of reverse transcriptase from feline immunodeficiency virus. J. Biol. Chem. 265:5121-5128.
- (1990) J. Biol. Chem. , vol.265 , pp. 5121-5128
- North, T.W.¹ Cronn, R.C.² Remington, K.M.³ Tandberg, R.T.⁴ Judd, R.C.⁵

35
- 0028123637
- Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coli
- North, T. W., G. L. Hansen, Y.-Q. Zhu, J. A. Grifin, and C.-K. Shih. 1994. Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coli. Antimiciob. Agents Chemother. 38:388-391.
- (1994) Antimiciob. Agents Chemother. , vol.38 , pp. 388-391
- North, T.W.¹ Hansen, G.L.² Zhu, Y.-Q.³ Grifin, J.A.⁴ Shih, C.-K.⁵

36
- 0029045521
- Testing HIV-1 drugs in the FIV model
- North, T. W, and R. A. LaCasse. 1995. Testing HIV-1 drugs in the FIV model. Nat. Med. 1:410-411.
- (1995) Nat. Med. , vol.1 , pp. 410-411
- North, T.W.¹ Lacasse, R.A.²

37
- 0024332802
- Feline immunodeficiency virus: A model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome
- North, T. W., G. L. T. North, and N. C. Pedersen. 1989. Feline immunodeficiency virus: a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob. Agents Chemother. 33: 915-919.
- (1989) Antimicrob. Agents Chemother. , vol.33 , pp. 915-919
- North, T.W.¹ North, G.L.T.² Pedersen, N.C.³

38
- 0024366204
- Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses
- Olmsted, R. A., V. M. Hirsch, R. H. Purcell, and P. R. Johnson. 1989. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA 86:8088-8092.
- (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 8088-8092
- Olmsted, R.A.¹ Hirsch, V.M.² Purcell, R.H.³ Johnson, P.R.⁴

39
- 0027219220
- In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease
- Otto, M. J., S. Garber, D. L. Winslow, C. D. Reid, P. Aldrich, P. K. Jadhav, C. E. Pattersen, C. N. Hodge, and Y.-S. E. Cheng. 1993. In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc. Natl. Acad. Sci. USA 90:7543-7547.
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 7543-7547
- Otto, M.J.¹ Garber, S.² Winslow, D.L.³ Reid, C.D.⁴ Aldrich, P.⁵ Jadhav, P.K.⁶ Pattersen, C.E.⁷ Hodge, C.N.⁸ Cheng, Y.-S.E.⁹

40
- 0030060362
- Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis
- Pandey, V. N., N. Kaushik, N. Rege, S. G. Sarafianos, P. N. S. Vadav, and M. J. Modak. 1996. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry 35:2168-2179.
- (1996) Biochemistry , vol.35 , pp. 2168-2179
- Pandey, V.N.¹ Kaushik, N.² Rege, N.³ Sarafianos, S.G.⁴ Vadav, P.N.S.⁵ Modak, M.J.⁶

41
- 0029052967
- Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase
- Patel, P. H., A. Jacobo-Molina, J. Ding, C. Tantillo, A. D. Clark, Jr., R. Raag, R. G. Nanni, S. H. Hughes, and E. Arnold. 1995. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34:5351-5363.
- (1995) Biochemistry , vol.34 , pp. 5351-5363
- Patel, P.H.¹ Jacobo-Molina, A.² Ding, J.³ Tantillo, C.⁴ Clark Jr., A.D.⁵ Raag, R.⁶ Nanni, R.G.⁷ Hughes, S.H.⁸ Arnold, E.⁹

42
- 0000539970
- The feline immunodeficiency virus
- J. A. Levy (ed.), Plenum Press, New York, N.Y.
- Pedersen, N. C. 1993. The feline immunodeficiency virus, p. 181-219. In J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
- (1993) The Retroviridae , vol.2 , pp. 181-219
- Pedersen, N.C.¹

43
- 0023137671
- Isolation of a T-lymphotrophic virus from domestic cats with an immunodeficiency-like syndrome
- Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotrophic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
- (1987) Science , vol.235 , pp. 790-793
- Pedersen, N.C.¹ Ho, E.W.² Brown, M.L.³ Yamamoto, J.K.⁴

44
- 0028344145
- Neurological abnormalities associated with feline immunodeficiency virus infection
- Phillips, T. R., O. Prospero-Garcia, D. L. Puaoi, D. L. Lerner, H. S. Fox, R. A. Olmsted, F. E. Bloom, S. J. Henriksen, and J. H. Elder. 1994. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75:979-987.
- (1994) J. Gen. Virol. , vol.75 , pp. 979-987
- Phillips, T.R.¹ Prospero-Garcia, O.² Puaoi, D.L.³ Lerner, D.L.⁴ Fox, H.S.⁵ Olmsted, R.A.⁶ Bloom, F.E.⁷ Henriksen, S.J.⁸ Elder, J.H.⁹

45
- 0027210361
- AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection
- Podel, M. N, M. Oglesbee, L. Mathes, S. Krakowka, R. Olmstead, and L. Lafredo. 1993. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J. Acquired Immune Defic. Syndr. 6:758-771.
- (1993) J. Acquired Immune Defic. Syndr. , vol.6 , pp. 758-771
- Podel, M.N.¹ Oglesbee, M.² Mathes, L.³ Krakowka, S.⁴ Olmstead, R.⁵ Lafredo, L.⁶

46
- 0026051129
- Mutants of feline immunodeficiency virus resistant to 3′-azido-3′-deoxythymidine
- Remington, K. M., B. Chesebro, K. Wehrly, N. C. Pedersen, and T. W. North. 1991. Mutants of feline immunodeficiency virus resistant to 3′-azido-3′-deoxythymidine. J. Virol. 65:308-312.
- (1991) J. Virol. , vol.65 , pp. 308-312
- Remington, K.M.¹ Chesebro, B.² Wehrly, K.³ Pedersen, N.C.⁴ North, T.W.⁵

47
- 0028012038
- Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase
- Remington, K. M., Y.-Q. Zhu, T. R. Phillips, and T. W. North. 1994. Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase. J. Virol. 68:632-637.
- (1994) J. Virol. , vol.68 , pp. 632-637
- Remington, K.M.¹ Zhu, Y.-Q.² Phillips, T.R.³ North, T.W.⁴

48
- 0027278781
- Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents
- Richman, D. D. 1993. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37: 1207-1213.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 1207-1213
- Richman, D.D.¹

49
- 0027957791
- Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
- Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignacio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Barringer, D. Pauletti, C. K. Shin, M. Myers, and J. Griffin. 1992. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666.
- (1992) J. Virol. , vol.68 , pp. 1660-1666
- Richman, D.D.¹ Havlir, D.² Corbeil, J.³ Looney, D.⁴ Ignacio, C.⁵ Spector, S.A.⁶ Sullivan, J.⁷ Cheeseman, S.⁸ Barringer, K.⁹ Pauletti, D.¹⁰ Shin, C.K.¹¹ Myers, M.¹² Griffin, J.¹³

50
- 0029838243
- Mutations in retroviral genes associated with drug resistance
- Schinazi, R. F., B. A. Larder, and J. W. Mellors. 1996. Mutations in retroviral genes associated with drug resistance. Int. Antiviral News 4:95-107.
- (1996) Int. Antiviral News , vol.4 , pp. 95-107
- Schinazi, R.F.¹ Larder, B.A.² Mellors, J.W.³

51
- 0027409698
- Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
- Schinazi, R. F., R. M. Lloyd, Jr., M.-H. Nguen, D. L. Cannon, A. McMillan, N. Ilksoy, C. K. Chu, D. C. Liotta, H. Z. Bazmi, and J. W. Mellors. 1993. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37:875-881.
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 875-881
- Schinazi, R.F.¹ Lloyd Jr., R.M.² Nguen, M.-H.³ Cannon, D.L.⁴ McMillan, A.⁵ Ilksoy, N.⁶ Chu, C.K.⁷ Liotta, D.C.⁸ Bazmi, H.Z.⁹ Mellors, J.W.¹⁰

52
- 0029024089
- Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant populations in persons treated with lamivudine (3TC)
- Schuurman, R., M. Nijhuis, R. van Leeuen, P. Schipper, D. de Jong, P. Collis, S. Danner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171:1411-1419.
- (1995) J. Infect. Dis. , vol.171 , pp. 1411-1419
- Schuurman, R.¹ Nijhuis, M.² Van Leeuen, R.³ Schipper, P.⁴ De Jong, D.⁵ Collis, P.⁶ Danner, S.⁷ Mulder, J.⁸ Loveday, C.⁹ Christopherson, C.¹⁰ Kwok, S.¹¹ Sninsky, J.¹² Boucher, C.A.B.¹³

53
- 0028273314
- Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
- Shafer, R. W., M. J. Kozal, M. A. Winters, A. K. N. Iversen, D. A. Katzenstein, M. V. Ragni, W. A. Meyer, P. Gupta, S. Rasheed, R. Coombs, M. Katzman, S. Ficus, and T. C. Merigan. 1994. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J. Infect. Dis. 169:722-729.
- (1994) J. Infect. Dis. , vol.169 , pp. 722-729
- Shafer, R.W.¹ Kozal, M.J.² Winters, M.A.³ Iversen, A.K.N.⁴ Katzenstein, D.A.⁵ Ragni, M.V.⁶ Meyer, W.A.⁷ Gupta, P.⁸ Rasheed, S.⁹ Coombs, R.¹⁰ Katzman, M.¹¹ Ficus, S.¹² Merigan, T.C.¹³

54
- 0031047825
- A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides
- Smith, R. A., K. M. Remington, R. M. Lloyd, Jr., R. F. Schinazi, and T. W. North. 1997. A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides. J. Virol. 71:2357-2363.
- (1997) J. Virol. , vol.71 , pp. 2357-2363
- Smith, R.A.¹ Remington, K.M.² Lloyd Jr., R.M.³ Schinazi, R.F.⁴ North, T.W.⁵

55
- 0025950055
- Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase
- St. Clair, M. H., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253:1557-1559.
- (1991) Science , vol.253 , pp. 1557-1559
- St Clair, M.H.¹ Martin, J.L.² Tudor-Williams, G.³ Bach, M.C.⁴ Vavro, C.L.⁵ King, D.M.⁶ Kellam, P.⁷ Kemp, S.D.⁸ Larder, B.A.⁹

56
- 0000523078
- Nucleotide sequence and genomic organization of feline immunodeficiency virus
- Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
- (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 5743-5747
- Talbott, R.L.¹ Sparger, E.E.² Lovelace, K.M.³ Fitch, W.M.⁴ Pedersen, N.C.⁵ Luciw, P.A.⁶ Elder, J.H.⁷

57
- 0028172345
- Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase
- Tantillo, C., J. Ding, A. Jacobo-Molina, R. G. Nanni, P. L. Boyer, S. H. Hughes, R. Pauwels, K. Andries, P. A. J. Janssen, and E. Arnold. 1994. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. J. Mol. Biol. 243:369-387.
- (1994) J. Mol. Biol. , vol.243 , pp. 369-387
- Tantillo, C.¹ Ding, J.² Jacobo-Molina, A.³ Nanni, R.G.⁴ Boyer, P.L.⁵ Hughes, S.H.⁶ Pauwels, R.⁷ Andries, K.⁸ Janssen, P.A.J.⁹ Arnold, E.¹⁰

58
- 0027285372
- Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
- Tisdale, M., S. D. Kemp, N. M. Parry, and B. A. Larder. 1993. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. USA 90:5653-5656.
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 5653-5656
- Tisdale, M.¹ Kemp, S.D.² Parry, N.M.³ Larder, B.A.⁴

59
- 13344294407
- Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase
- Wainberg, M. A., W. C. Drosopoulos, H. Salomon, M. Hsu, G. Borkow, M. A. Parniak, Z. Gu, Q. Song, J. Manne, S. Islam, G. Castriota, and V. R. Prasad. 1996. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271:1282-1285.
- (1996) Science , vol.271 , pp. 1282-1285
- Wainberg, M.A.¹ Drosopoulos, W.C.² Salomon, H.³ Hsu, M.⁴ Borkow, G.⁵ Parniak, M.A.⁶ Gu, Z.⁷ Song, Q.⁸ Manne, J.⁹ Islam, S.¹⁰ Castriota, G.¹¹ Prasad, V.R.¹²

60
- 0029920290
- Human immunodeficiency virus type-1 reverse transcriptase; contribution of Met-184 to binding of nucleoside 5′-triphosphate
- Wilson, J. E., A. Aulabaugh, B. Caligan, S. McPherson, J. K. Wakefield, S. Jablonski, C. D. Morrow, J. E. Reardon, and P. A. Furman. 1996. Human immunodeficiency virus type-1 reverse transcriptase; contribution of Met-184 to binding of nucleoside 5′-triphosphate. J. Biol. Chem. 271:13656-13662.
- (1996) J. Biol. Chem. , vol.271 , pp. 13656-13662
- Wilson, J.E.¹ Aulabaugh, A.² Caligan, B.³ McPherson, S.⁴ Wakefield, J.K.⁵ Jablonski, S.⁶ Morrow, C.D.⁷ Reardon, J.E.⁸ Furman, P.A.⁹

61
- 0024058465
- Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats
- Yamamoto, J. K., E. Sparger, E. W. Ho, P. R. Andersen, T. P. O'Connor, C. P. Mandell, L. Lowenstine, R. Munn, and N. C. Pedersen. 1988. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49:1246-1258.
- (1988) Am. J. Vet. Res. , vol.49 , pp. 1246-1258
- Yamamoto, J.K.¹ Sparger, E.² Ho, E.W.³ Andersen, P.R.⁴ O'Connor, T.P.⁵ Mandell, C.P.⁶ Lowenstine, L.⁷ Munn, R.⁸ Pedersen, N.C.⁹

62
- 9544227480
- Mutants of feline immunodeficiency virus resistant to 2′,3′-dideoxy-2′,3′-didehydrothymidine
- Zhu, Y.-Q., K. M. Remington, and T. W. North. 1996. Mutants of feline immunodeficiency virus resistant to 2′,3′-dideoxy-2′,3′-didehydrothymidine. Antimicrob. Agents Chemother. 40:1983-1987.
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 1983-1987
- Zhu, Y.-Q.¹ Remington, K.M.² North, T.W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.